Okoliegbe, IjeomaHijazi, KarolinCooper, KimIronside, CorinneGould, Ian2021-09-292021-09-292021-05-18Okoliegbe, I, Hijazi, K, Cooper, K, Ironside, C & Gould, I 2021, 'Trends of antimicrobial resistance and combination susceptibility testing of cystic fibrosis multidrug-resistant Pseudomonas aeruginosa : A ten-year update', Antimicrobial Agents and Chemotherapy, vol. 65, no. 6, e02483-20. https://doi.org/10.1128/AAC.02483-200066-4804https://hdl.handle.net/2164/17220Acknowledgements The authors would like to thank the laboratories and clinicians who use the Cystic Fibrosis Antibiotics Susceptibility testing service (CFASS) for their support in sending samples. CFASS is an adult patient testing facility funded by the National Services Division of the Common Services Agency. IMG serves as a consultant to and/ speaker to Pfizer and MSD. All other authors declare no competing interests.10303589engPseudomonas aeruginosaCystic FibrosisAntimicrobial susceptibility testingSynergy testingEtestR MedicineRJournal article10.1128/AAC.02483-20656